QUANTIFICATION OF LIPOPROTEIN(A) IN PLASMA BY ASSAYING CHOLESTEROL INLECTIN-BOUND PLASMA FRACTION

Citation
Lj. Seman et al., QUANTIFICATION OF LIPOPROTEIN(A) IN PLASMA BY ASSAYING CHOLESTEROL INLECTIN-BOUND PLASMA FRACTION, Clinical chemistry, 40(3), 1994, pp. 400-403
Citations number
27
Categorie Soggetti
Chemistry Medicinal
Journal title
ISSN journal
00099147
Volume
40
Issue
3
Year of publication
1994
Pages
400 - 403
Database
ISI
SICI code
0009-9147(1994)40:3<400:QOLIPB>2.0.ZU;2-P
Abstract
Lipoprotein(a) [Lp(a)] is a low-density lipoprotein (LDL)-like particl e in which apolipoprotein(a) [apo(a)] is disulfide-linked to apolipopr otein B (apoB). High concentrations of Lp(a) in plasma are associated with an increased risk of coronary heart disease (CHD). Lp(a) has trad itionally been measured by immunoassay and expressed as total mass of Lp(a). Measuring Lp(a) by its cholesterol content will provide a way t o directly compare Lp(a) with other lipoproteins that are measured by cholesterol. We have developed an assay to quantify Lp(a) by its chole sterol content [Lp(a)-C], using lectin affinity to isolate Lp(a) from other lipoproteins, and then measuring the cholesterol within the isol ated fraction. We compared the Lp(a)-C assay with an ELISA for Lp(a) m ass in 47 plasma samples from normotriglyceridemic, fasting individual s with high Lp(a) contents (mean +/- SD, 446 +/- 350 mg/L). The mean L p(a)-C concentration was 110 +/- 89 mg/L and correlated very highly wi th Lp(a) mass (r = 0.9975). Lp(a)-C measurement is an alternative meth od to screen for this CHD risk factor.